Peer-reviewed Publications

Peer-reviewed Publications

PubMed search, 72 citations (updated March 2023)


Clinical Research: Dr Salam Iriqat MD (Clinical Research Coordinator)

Laboratory Research: Dr Ala’a Al Talbishi, MD PhD

Publications by colleagues working at SJEHG or the SOA.
(Bold indicating relevant Author: SJEHG doctor, visitor reporting from St John, or SOA publications *)


2022 (4)

(72) Daich Varela M, Georgiou M, Alswaiti Y, Kabbani J, Fujinami K, Fujinami-Yokokawa Y, Khoda S, Mahroo OA, Robson AG, Webster AR, AlTalbishi A, Michaelides M. CRB1-Associated Retinal Dystrophies: Genetics, Clinical Characteristics, and Natural History. Am J Ophthalmol. 2023 Feb;246:107-121. doi: 10.1016/j.ajo.2022.09.002. Epub 2022 Sep 12. PMID: 36099972.

(71) Corradi Z, Salameh M, Khan M, Héon E, Mishra K, Hitti-Malin RJ, AlSwaiti Y, Aslanian A, Banin E, Brooks BP, Zein WM, Hufnagel RB, Roosing S, Dhaenens CM, Sharon D, Cremers FPM, AlTalbishi A. ABCA4 c.859-25A>G, a Frequent Palestinian Founder Mutation Affecting the Intron 7 Branchpoint, Is Associated With Early-Onset Stargardt Disease. Invest Ophthalmol Vis Sci. 2022 Apr 1;63(4):20. doi: 10.1167/iovs.63.4.20. PMID: 35475888; PMCID: PMC9055564.

(70) Yogeswaran K, Furtado JM, Bodaghi B, et al (incl. Iriqat S)Current practice in the management of ocular toxoplasmosis. 

(69) Testi I, Brandão-de-Resende C, Agrawal R, Pavesio C; COVID-19 Vaccination Ocular Inflammatory Events Study Group (incl. Iriqat S). Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12:4.

2021 (10)

(68) Shalabi O, Nazzal Z, Natsheh M, Iriqat S, Michaelides M, Ghanem M, Aslanian A, Alswaiti Y, AlTalbishi A. Swept-source optical coherence tomography changes and visual acuity among Palestinian retinitis Pigmentosa patients: a cross-sectional study. BMC Ophthalmol 21, 289 (2021).

(67) Banayot R, Swaiti Y, Al-hashash I. Acute ocular chemical injury: a descriptive assessment and management review at St. John Eye Hospital, Jerusalem, Palestine Ophthalmol J 2021;6:171-177.

(66) Yahalom C, Volovelsky O, Macarov M, Altalbishi A, Alsweiti Y. SENIOR-LØKEN SYNDROME: A Case Series and Review of the Renoretinal Phenotype and Advances of Molecular Diagnosis. Retina. 2021;41:2179-2187.

(65) Sangermano R, Deitch I, Peter VG, Ba-Abbad R, et al (incl. Al Talbishi A). Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD. NPJ Genom Med. 2021;6:53.

(64) Abu Hantash A, Abu Safieh M, Iriqat S, Daraghmeh M. Bilateral Abducens Nerve Palsy and the possible Association with COVID-19: A Case Report. J. Archives of Medical Case Reports and Case Study:2021;4(4)

(63) BattaH, DaraghmehM, Abu Safyia M, et al (incl. Iriqat S). The Incidence of Consecutive Exotropia Following Surgical Correction of Childhood Esotropia, and Associated Risk Factors in St John Eye Hospital. Acta Scientific Ophthalmology 2020;4(10):42-47.

(62) Iriqat S, Safieh MA, Fatouleh M, Alkaiyat A. Blau syndrome: a case report from Palestine. Pediatr Rheumatol Online J. 2021 Aug 31;19(1):138. doi: 10.1186/s12969-021-00633-y. PMID: 34465352; PMCID: PMC8406922.

(61) Iriqat S, Yousef Q, Ereqat S. Clinical Profile of COVID-19 Patients Presenting with Uveitis – A Short Case Series. Int Med Case Rep J. 2021;14:421-427

(60) Sangermano R, Deitch I, Peter VG, et al  (incl Al Talbishi A).Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD. NPJ Genom Med. 2021;6:53.

(59) Maswadi R, Bascaran C, Clare G, Ramada MA, Al Talbishi A, Foster A. Cataract Surgical Services in Palestine. Ophthalmic Epidemiol. 2021 Jun 13:1-9. doi: 10.1080/09286586.2021.1923755. Epub ahead of print. PMID: 34121602.

2020 (4)

(58) Kang S, Hamed-Azzam S, Robertson F, Davagnanam I, Verity DH. Pulsating lid: a rare presentation of sinus pericranii. Can J Ophthalmol. 2020;55:e100-e104.

(57) McMaster D, Clare G. Integrating specialist ophthalmic services into emergency medical teams. Bull World Health Organ. 2020 Oct 1;98:722-724.

(56) McMaster D, Clare G. Incidence of ocular blast injuries in modern conflict.Eye (Lond). 2020 Dec 11. doi: 10.1038/s41433-020-01359-z. Online ahead of print.

(55) Khan M, Cornelis SS, Pozo-Valero MD, et al  (incl Al Swaiti Y, Al Talbishi A). Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics. Genet Med. 2020;22:1235-1246.

(54) * Hamed Azzam S, Verity DH, Briscoe D, Mathewson P, Rose G. Infectious Processes of the Orbit In: Albert and Jakobiec’s “Principles and Practice of Ophthalmology”, 4E. Saunders, Philadelphia, In press.

2019 (3)

(53) Spivey B. The Most Venerable Order of the Hospital of St. John of Jerusalem: Providing Eye Care Where None Exists. February, 2019.

(52) Al Talbishi A, Zelinger L, Zeitz C, et al. TRPM1 Mutations are the Most Common Cause of Autosomal Recessive Congenital Stationary Night Blindness (CSNB) in the Palestinian and Israeli Populations. Sci Rep. 2019;9:12047.

(51) Abu Diab A, Al Talbishi A, Rosin B, et al. The combination of whole-exome sequencing and clinical analysis allows better diagnosis of rare syndromic retinal dystrophies. Acta Ophthalmol. 2019;97:e877-e886.

2018 (5)

(50) Khalaileh A, Abu-Diab A, Ben-Yosef T, et al (incl. Al Swaiti Y). The Genetics of Usher Syndrome in the Israeli and Palestinian Populations. Invest Ophthalmol Vis Sci. 2018;59:1095-1104.

(49) Banayot RG. Inter-grader agreement in the diabetic retinopathy screening program in Palestine. Ibnosina J Med Biomed Sci 2018;10:193-7

(48) Banayot RG. The profile of eye disease in palestine: An 8-year experience at St. John Eye Hospital, Hebron. Ibnosina J Med Biomed Sci 2018;10:130-5

(47) * Hamed-Azzam S, Al Hashash I, Briscoe D, Rose GE, Verity DH. Common orbital infections ~ State of the art ~ Part I. JOVR 2018;13:175-182.

(46) * Hamed-Azzam S, Al Hashash I, Briscoe D, Rose GE, Verity DH. Rare orbital infections ~ State of the art ~ Part II. JOVR 2018;13:183-190.

2016 (1)

(45) Banayot RG. A retrospective analysis of eye conditions among children attending St. John Eye Hospital, Hebron, Palestine. BMC Res Notes. 2016;9:202.

2015 (1)

(44) Al Talbishi A, Khateb S, Amer R. Elschnig’s spots in the acute and remission stages in preeclampsia: spectral-domain optical coherence tomographic features. Eur J Ophthalmol. 2015;25:e84-e87.

2011 (1)

(43) Keenan TD, Sargent NJ. Enucleation and evisceration in the Palestinian territories. Middle East Afr J Ophthalmol. 2011;18:170-172.

2010 (1)

(42) Chiang F, Kuper H, Lindfield R, Keenan T, Seyam N, Magauran D, Khalilia N, Batta H, Abdeen Z,  Sargent N. Rapid assessment of avoidable blindness in the Occupied Palestinian Territories. PloS one;2010 5, e11854.

2009 (2)

(41) Claesson M, Armitage WJ, Olsson-Abdellatif K, Sargent N. Corneal transplant outcome in the Palestinian territories: a 2-year follow-up study. Eye (Lond). 2009;23:1423-1426.

(40) Norman PJ, Abi-Rached L, Gendzekhadze K, et al (incl. Verity DH). Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res. 2009;19:757-69.

2007 (2)

(39) Norman PJ, Abi-Rached l, Gendzekhadze K, et al (incl. Verity DH). Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 2007;39:1092-9.

(38) Wallace GR, Kondeatis E, Vaughan RW, et al (incl. Verity DH, Kanawati C.) IL-10 Genotype Analysis in Patients with Behcet’s Disease. Hum Immunol. 2007;68:122-7.

2005 (1)

(37) Ahmad T, Zhang L, Gogus F, et al (incl. Verity DH). CARD15 polymorphisms in Behçet’s disease. Scand J Rheumatol. 2005;34:233-7.

2004 (2)

(36) Yang X, Ahmad T, Gogus F, et al (incl. Verity DH, Kanawati C). Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet’s disease. Eur J Immunogenet 2004;31:11-4.

(35) Norman PJ, Cook MA, Carey BS, (incl. Verity DH). SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex. Immunogenetics. 2004;56:225-37

2003 (1)

(34) Verity DH, Wallace GR, Vaughan RW, Stanford MR.  Behçet’s disease: From Hippocrates to the third Millennium. Br J Ophthalmol 2003;87:1176-1184.

2002 (3)

(33) Abu-Ramadan MA. Making better use of scarce resources: the Palestinian experience, 1995-1999. J Ambul Care Manage. 2002;25:63-69.

(32) Norman PJ, Carrington CV, Byng M, et al (incl. Verity DH). Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun. 2002;3:86-95.

(31) Stanford MR, Verity DH.  Diagnostic and therapeutic approaches to patients with retinal vasculitis. In: International ophthalmology clinics: advances in uveitis. Ed Cunningham ET. Philadelphia, Lippincott Williams and Wilkins 2000; 69 – 81.

2001 (4)

(30) Verity DH, Magauran DM. Crouzon’s Disease. Br J Ophth Photography 2001; 4: 5 – 7.

(29) Mizuki N, Yabuki K, Ota M, et al (incl. Verity DH). Microsatellite mapping of a susceptible locus within the HLA region for Behçet’s disease using Jordanian patients. Human Immunology 2001; 62: 186 – 190.

(28) Norman PJ, Stephens HAF, Verity DH, et al. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 2001;52:195-205

(27) Wallace GR, Edelsten CE, Vaughan RW, (incl. Verity DH). The HLA class II haplotype DRB1*1501-DQB1*0602 predicts disease outcome in patients with retinal vasculitis. Immunology 2001; S104: 1:109.

2000 (4)

(26) O’Shea JG. A survey of vernal keratoconjunctivitis and other eosinophil-mediated external eye diseases amongst Palestinians. Ophthalmic Epidemiol. 2000;7(2):149-157.

(25) Verity DH.   Behçet’s Disease. CME Journal of Ophthalmology 2000; 4 (3): 75 – 78.

(24) Stanford MR, Verity DH.  Diagnostic and therapeutic approaches to patients with retinal vasculitis. Int Ophthalmol Clin 2000; 40: 69 – 83.

(23) Verity DH, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, Fayyad F,  Marr JE, Kanawati CA,  Wallace GR, Stanford MR.  Intercellular adhesion molecule-1 gene polymorphisms in Behçet’s Disease.  Eur J Immunogen 2000; 27: 73 – 6.

1999 (7)

(22) O’Shea JG. The St John Ophthalmic Hospital: a medical ambassador in Jerusalem. Eye (Lond). 1999;13:270-272.

(21) Verity DH, Tarazzi A, Tyers A, Magauran D.   Neurosurgical cure for pulsating lid lesion. Br J Ophth Photography 1999; 2: 14 – 15.

(20) Wallace GR, Verity DH, Delamaine L, et al (incl. Kanawati C). MIC-A allele profiles and HLA class-1 Associations in Behçet’s disease. Immunogenetics 1999; 49: 613 – 617.

(19) Verity DH, Lee W, Pyott A. Morning glory syndrome and a mobile posterior segment. Br J Ophth Photography 1999; 2: 30 – 31.

(18) Verity DH, Vaughan RW, Madanat W, et al (incl. Kanawati C).  Factor V Leiden mutation is associated with ocular involvement in Behçet’s disease.  Am J Ophthalmol 1999; 128: 352 – 356.

(17) Verity DH, Wallace GR, Vaughan RW, et al.   HLA and TNF polymorphisms in ocular Behçet’s disease. Tissue Antigens 1999; 54: 264 – 72.

(16) Verity DH, Marr JE, Wallace GR, Stanford MR. Behçet’s disease, the Silk Road and HLA-B51: Historical and geographical perspectives.   Tissue Antigens 1999; 54:  213 – 220.

1998 (2)

(15) Verity DH, Wallace GR, Seed P, Kanawati C, Ayesh I, H Gladwish J, Stanford MR. Soluble adhesion molecules in Behçet’s disease. Ocular Immunology and Inflammation 1998; 6: 81 – 92.

(14) Wallace GR, Verity DH, Delamaine L, et al. MIICA9 allele is associated with Behcet’s disease in Middle Eastern Patients. Immunology – Supplement 1998;95 Supplement 1:4.

1997 (6)

(13) O’Shea JG. Lacrimal surgery at St John, Jerusalem. J R Coll Surg Edinb. 1997;42:42-44.

(12) O’Shea JG. A history of the St John Ophthalmic Hospital, Jerusalem. Proc R Coll Physicians Edinb. 1997;27:603-610.

(11) Jaouni ZM, O’Shea JG. Surgical management of ophthalmic trauma due to the Palestinian Intifada. Eye (Lond). 1997;11:392-397.

(10) Verity DH, Stanford MR, Vaughan R, et al (incl. Kanawati C). The role of Tumour Necrosis Factor a in ocular Behçet’s disease. p 165 – 6. In: UVEITIS TODAY. Ed. Ohno S et al.. Proc 4th Int Symp Uveitis, Japan, 1997.

(9) Verity DH, Madanat W, Kanawati CA, et al.  Visual Morbidity in Palestinian and Jordanian Patients with ocular Behçet’s disease.  p 167 – 168.  In: UVEITIS TODAY. Ed. Ohno S et al. Proc 4th Int Symp Uveitis, Japan, 1997.

(8) Kanawati CA, Verity DH, Holland Gladwish J, Stanford M. Cyclosporine in the Management of Palestinian Patients with Behçet’s disease. p145 – 149.   In: UVEITIS TODAY. Ed. Ohno S et al.. Proc 4th Int Symp Uveitis, Japan, 1997.

1996 (2)

(7) Jaouni ZM, O’Shea JG. Civilian eye casualties in east Jerusalem and the occupied territories. Med Confl Surviv. 1996;12:138-148.

(6) Kanawati CA, Verity DH, Holland-Gladwish J, Stanford MR. Cyclosporine in the management of Palestinian Patients with Behçet’s disease.  p 432 – 434.   In: BEHÇET’S DISEASE. Proc 7th Int Conf on Behçet’s Disease 1996.  Ed. Hamza M’Hamed, Pub Adhoua Press. ISBN 9973 17 850 5.

1990 (1)

(5) Chumbley LC, Morgan AM, Musallam I. Hydroxypropyl methylcellulose in extracapsular cataract surgery with intraocular lens implantation: intraocular pressure and inflammatory response. Eye (Lond). 1990;4:121-126.

1988 (3)

(4) Chumbley LC, Thomson IM. Epidemiology of trachoma in the West Bank and Gaza Strip. Eye (Lond). 1988;2:463-470.

(3) Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Treatment of trachoma in the West Bank. Eye (Lond). 1988;2:471-475.

(2) Chumbley LC. Herbert’s pits and lid concretions: an important association. Eye (Lond). 1988;2:476-477.

1984 (1)

(1) Thomson IM, Chumbley LC. Eye disease in the West Bank and Gaza strip. Br J Ophthalmol. 1984;68:598-602.